• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Latest News about AGNPF

    Recent news which mentions AGNPF

    Psyched: DEA Revisits Ban On Two Psychedelics, Farewell Russell Newcombe, Podcast Episode On Kanna & More
    Tickers AGNPF ATAI CMND CMPS
    Tags CMPS Benzinga Psychedelics Research
    From Benzinga
    DMT For Stroke Treatment: Algernon Sets Phase 2 Clinical Trial Design
    Tickers AGNPF
    Tags DMT/Assisted Therapy Cannabis Psychedelics
    From Benzinga
    Psyched: Professional Practice Guidelines, DMT For Stroke, Dua Lipa &. Amanda Feilding, Clinical Results & More
    Tickers AGNPF ATAI AWKNF CMPS
    Tags PMBHF CYBN IXHL
    From Benzinga
    DMT As A Treatment For Stroke? This Company Is Closer To Launching Its Phase 2 Study
    Tickers AGNPF
    Tags Algernon NeuroScience premium Benzinga
    From Benzinga
    DMT's Clinical Path For Treating TBI And Stroke: Phase 1 Dosing Finished As Phase 2 Gears Up
    Tickers AGNPF
    Tags Market News News Penny Stocks
    From Benzinga
    How To Finance A Psychedelics Business? Learn From These Four Companies
    Tickers AGNPF CMND PSYGF
    Tags Penny Stocks Psychedelic/Assisted Therapies Diamond Therapeutics Inc/
    From Benzinga
    Intravenous DMT Therapy Seeks Ideal Dosage For Stroke And TBI Treatment
    Tickers AGNPF
    Tags Penny Stocks Human Stroke Psychedelic/Assisted Therapies
    From Benzinga
    Psyched: 9 US Reform Bills, Ayahuasca 'A Release' For Prince Harry, At-Home Therapy & More
    Tickers AGNPF AWKNF BRAXF CMPS
    Tags CYBN News GHRS
    From Benzinga
    Algernon Pharmaceuticals AP-188 DMT Compound Shows Promise For The Treatment Of TBI
    Tickers AGNPF
    Tags Benzinga contributors Market News
    From Benzinga
    Algernon Pharmaceuticals Goes 4:1 In Forward Share Split After Announcing New TBI Program
    Tickers AGNPF IPOS
    Tags Market News News Benzinga Psychedelics Capital Conference
    From Benzinga
    Psyched: Hawaii And Minnesota's Bills, Studying 2C-B Vs. Psilocybin, Filament CEO, Plus Brock Pierce And Jeremy Gardner Discuss The Industry's Future And More
    Tickers AGNPF AWKNF CMND CYBN
    Tags Financing AGNPF Sector ETFs
    From Benzinga
    Psyched: Four New States With Reform Bills, Psilocybin For Genetic Disorders And Functional Neurological Disorder, Struggle For Access & More
    Tickers AGNPF AWKNF CYBN DMTTF
    Tags PSYK TRUFF Penny Stocks
    From Benzinga
    Developing Psychedelic Treatments For Traumatic Brain Injury: Algernon Launches New Program
    Tickers AGNPF TBI
    Tags Benzinga AGN Neuro AGNPF
    From Benzinga
    Algernon Touts Positive Study Findings, Confirms Next Trial Phase With Escalated Dose
    Tickers AGNPF
    Tags Benzinga AGNPF Health Care
    From Benzinga
    A Psychedelic Program For Treatment Of Stroke: New Clinical Trial Begins Dosing
    Tickers AGNPF DMT
    Tags Benzinga AGNPF Markets
    From Benzinga
    Psychedelic Subsidiaries News: Blackhawk Spins Out Three Companies, Algernon Creates A New One
    Tickers AGNPF
    Tags MindBio Therapeutics Corp/ Penny Stocks Market News
    From Benzinga
    EXCLUSIVE: Ayahuasca Pill Is Officially Here, Filament CEO Discusses Future Plans
    Tickers AGNPF ATAI FLHLF
    Tags General Top Stories Exclusives
    From Benzinga
    Psyched: Musk's Empathy Tweets, Psychedelics In Congress, Oregon's Opt-Outs, MAPS' MDMA Trial And More
    Tickers AGNPF BMNDF CMND CMPS
    Tags MSSTF BMNDF KONEF
    From Benzinga
    Psychedelic Therapeutics For Human Stroke: Participant Screening Expects To Begin Soon
    Tickers AGNPF
    Tags News AGNPF Market News
    From Benzinga
    Tackling Depression With Psychedelics: New Phase 2 Clinical Study Begins At Yale University
    Tickers AGNPF
    Tags DMT Clinical Trial Markets Psychedelics
    From Benzinga
    A Foundational Study On Stroke Is Ready. Here Is Why It's Important
    Tickers AGNPF DMT
    Tags Centre for Human Drug Research AGNPF The Netherlands
    From Benzinga
    Canadian Psychedelics Company To Begin First Global DMT Clinical Trial For Stroke Treatment
    Tickers AGNPF
    Tags Global Management Penny Stocks
    From Benzinga
    Algernon Pharmaceuticals Closes Private Placement Round, Announces New Shareholder Distribution
    Tickers AGNPF
    Tags AGNPF Benzinga Asset Sales
    From Benzinga
    Algernon Posts Mixed Bag Results From Mid Stage Chronic Cough Study
    Tickers AGNPF
    Tags Briefs Biotech Health Care
    From Benzinga
    Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation
    Tickers AGNPF ALID ATAI AWKNF
    Tags PSIL Fabio Chianelli WSNAF
    From Benzinga
    There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are
    Tickers AGNPF ALID ATAI AWKNF
    Tags psychedelics SILFF SILO
    From Benzinga
    Psyched: CaamTech Raises $22M, Mydecine To Launch Smoking Cessation Trial, Michigan Bill Could Decriminalize Psychedelics
    Tickers AGNPF ALID ATAI FTRP
    Tags MSSTF Markets Octarine Bio
    From Benzinga
    Investors Should Avoid High-Risk Atossa Therapeutics
    Tickers AGNPF ATOS GILD LLY
    Tags ATOS GILD NASDAQ:ATOS, NYSE:LLY,OTC:AGNPF,NASDAQ:SRNE,NASDAQ:GILD
    From InvestorPlace
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.